Live feed
Filing
SC 13G/A
SC 13G/A0000950103-17-001128·Baxalta Inc
Schedule 13G ownership disclosure
CTI BIOPHARMA CORP
Security class unavailable · CUSIP: 12648L106
Event date: 2017-01-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950103-17-001128
- Form type
- SC 13G/A
- Filer
- Baxalta Inc
- CIK
- CIK 1620546
- Filed
- Feb 06, 2017
- Reporting period
- Jan 01, 2017
- Description
- Schedule 13G beneficial ownership